CoChat

A Bayesian approach to randomized controlled trials in children utilizing information from adults: the case of Guillain-Barre

Goodman, Steven N, Sladky, John T · 2005 · Clinical Trials

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Background Guillain-Barré syndrome (GBS) is a rare neurologic disease that occurs at all ages, causing a progressive, ascending paralysis that usually resolves over weeks or months. The disease appears to be identical in children and adults, except that children recover more quickly, with fewer residua. For patients who lose the ability to walk independently, the main treatment options are plasmapheresis or intravenous immune globulin (IVIg), treatments that have shown to have identical effectiveness in adults in two large RCTs involving 388 patients. The effectiveness of the treatments in children has only been studied in small, poorly controlled studies. If one could capture all eligible patients in the United States, only about 100–300 children would be available for a trial annually. Methods The goal of this case was to demonstrate how Bayesian methods could be used to incorporate prior information on treatment efficacy from adults to design a randomized noninferiority trial of IVIg versus plasmapheresis in children. A Bayesian normal–normal model on the hazard ratio of time to independent walking was implemented. Results An evidence-based prior was constructed that was equivalent to 72 children showing exact equivalence between the therapies. A design was constructed based on a Bayesian normal–normal model on the hazard ratio, yielding a sample size of 160 children, with a preposterior analysis demonstrating a “Type I” error rate of 5% and a power of 77%. Conclusions This case study illustrates a rational approach to constructing an evidence-based prior that would allow information from adults to formally augment data from children to minimize unnecessary pediatric experimentation. The frequentist properties of a Bayesian design can be evaluated and reported as they would be for a standard design. Discussion of the appropriate prior for such designs is both a necessary and desirable feature of Bayesian trials.

Overview

Integrity signals

Registry

Crossref · 10.1191/1740774505cn102oa

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 19 references

Cited by

See all 50

Metadata

Authors
Goodman, S. N., & Sladky, J. T.
Affiliations
  • Johns Hopkins University (US)
  • Emory University (US)
Venue
Clinical Trials
Published
2005-08
Volume
2
Issue
4
Pages
305-310
ISSN
  • 1740-7745 (ISSN-L)
  • 1740-7753
OpenAlex
W2055605178
Cited by
50
References
19
Citations by year
2026: 1 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 1 · 2020: 1 · 2019: 3 · 2018: 8 · 2017: 5 · 2016: 8 · 2015: 1 · 2014: 3 · 2013: 1 · 2012: 4
FWCI
0.35
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Clinical Trials (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods and Bayesian Inference
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
Keywords
Guillain-Barré syndrome, pediatric clinical trials, plasmapheresis, intravenous immunoglobulin, hazard ratio, trial design, sample size determination, preposterior analysis
MeSH terms
Adult, Bayes Theorem, Child, Humans, Plasmapheresis, Randomized Controlled Trials as Topic, Walking, Immunoglobulins, Intravenous, Treatment Outcome, Evidence-Based Medicine, Guillain-Barre Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Bayesian approach to randomized controlled trials in children utilizing information from adults: the case of Guillain-Barre. https://app.cochat.ai/papers/10.1191/1740774505cn102oa
The paper
Goodman, S. N., & Sladky, J. T. (2005). A Bayesian approach to randomized controlled trials in children utilizing information from adults: the case of Guillain-Barre. Clinical Trials. https://doi.org/10.1191/1740774505cn102oa

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.